Plexigen plexigen.com


Public lists: Pharma Startups (6570)

Company developing an 3-D biochip to enhance the capacity, efficiency, accuracy and automation of gene screening. The technology was originally developed at North Carolina State University.

Company developing an 3-D biochip to enhance the capacity, efficiency, accuracy and automation of gene screening. The technology was originally developed at North Carolina State University.

Company (Alive / Active)

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Plexigen $0M Oct 10, 2019
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Plexigen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

HTG Molecular Diagnostics

Tucson, Arizona, United States
IPO / Went publicHTG Molecular Diagnostics provides simple, cost effective solutions for accurate RNA testing. In 2013 the company commercialized its Edge instrument platform and a portfolio of mRNA assays that leverage HTG's proprietary nuclease protection chemistry. The capability of the Edge System has been expanded to fully automate sample and targeted library preparation for next-generation sequencing.Login to see details

GlycoFi

Lebanon, New Hampshire, United States
AcquiredGlycoFi, Inc. was founded in 2000 with the mission of dramatically improving the capacity and cost of producing human therapeutic proteins, while simultaneously enhancing their efficacy and safety as therapeutics. The company harnesses the inherent advantages of yeast and other fungal-based protein expression systems by engineering these systems to produce correctly glycosylated human therapeutic proteins, thus greatly increasing the efficiency, fidelity and scalability at which those proteins c...Show allLogin to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)